Pier Capital’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Sell |
424,148
-31,279
| -7% | -$288K | 0.6% | 80 |
|
|
2025
Q1 | $3.91M | Buy |
455,427
+13,512
| +3% | +$116K | 0.65% | 74 |
|
|
2024
Q4 | $4.75M | Buy |
+441,915
| New | +$4.75M | 0.68% | 80 |
|
|
2023
Q1 | – | Sell |
-280,854
| Closed | -$2.6M | – | 110 |
|
|
2022
Q4 | $2.6M | Sell |
280,854
-103,957
| -27% | -$963K | 0.43% | 91 |
|
|
2022
Q3 | $3.97M | Buy |
384,811
+632
| +0.2% | +$6.52K | 0.68% | 73 |
|
|
2022
Q2 | $3.85M | Sell |
384,179
-104,515
| -21% | -$1.05M | 0.66% | 73 |
|
|
2022
Q1 | $6.02M | Buy |
488,694
+212,350
| +77% | +$2.61M | 0.77% | 74 |
|
|
2021
Q4 | $4.79M | Buy |
276,344
+161
| +0.1% | +$2.79K | 0.51% | 89 |
|
|
2021
Q3 | $4.96M | Buy |
+276,183
| New | +$4.96M | 0.51% | 93 |
|